Clinical trial
Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass: A Double Blind Randomized Controlled Trial.
NCT01802619 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass: A Double Blind Randomized Controlled Trial.
- Lead sponsor
- Xijing Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- June 30, 2016
- Enrollment
- 217 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac valve replacement complication, heart valve diseases, heart; complications, valve, prosthesis